SHPH SHUTTLE PHARMACEUTICALS HOLDINGS INC Capital Structure Changes 8-K Filing 2025 - Public Offering On March 12, 2025, Shuttle Pharmaceuticals Holdings, Inc. entered into an Underwriting Agreement for a public offering of 1,340,921 shares at $0.30 each and pre-funded warrants, raising approximately $5.2 million to fund its Phase II clinical trial and for marketing purposes. The offering closed on March 13, 2025, and the company believes it is now compliant with Nasdaq's minimum stockholders equity requirement after this offering.Get access to all SEC 8-K filings of the SHUTTLE PHARMACEUTICALS HOLDINGS INC